FDA Approves At-Home SARS-CoV-2 Test
- November 18, 2020
The AP (11/17, Perrone) reports that the FDA “on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed and developed entirely at home.”
Reuters (11/17, Kalia) reports that “the single-use test, made by Lucira Health, has been given emergency use authorization for home use with self-collected nasal swab samples in individuals age 14 and older who are suspected of COVID-19 by their health care provider, the FDA said.”
NPR (11/17, Romo) reports, “The test, which works by swirling the self-collected sample in a vial which is then placed in a test unit, can provide results in 30 minutes or less, according to the agency.” NPR adds, “The unit’s light-up display shows whether a person is positive or negative for the SARS-CoV-2 virus.”
The Hill (11/17, Folley) also covers the story.